Coronavirus speeds up time for Pomezia-Oxford vaccine: already tested on 320 volunteers, “first 100 million doses in December”



[ad_1]

Coronavirus Special – subscribe to the electronic newsletter
Get the latest updates in your inbox.

To date, more than 320 have already been administered volunteers and may be available already in december. Times speed up by Covid vaccine who is working on it Jenner Institute of Oxford University with the Italian company society Advent-IRBM of Pomezia. The pharmaceutical multinational AstraZeneca she joined the team and reached an agreement with Jenner: she will be responsible for the development, production and distribution of the vaccine worldwide. “We want to be ready with 100 million doses by the end of the year and then expand, “he announced on Financial times the company’s chief executive, p.Ascal Soriot.

Coronavirus, the Italian vaccine tested at Oxford for testing on 6000 volunteers
Also read

Coronavirus, the Italian vaccine tested at Oxford for testing on 6000 volunteers

A model is expected to be adopted for the duration of the pandemic. “Not for profit‘That is, without profit margins. The human clinical trial, after the positive results already obtained in the laboratory and in the monkeys, started in 5 centers in England last April 23 in 550 healthy volunteers and in another 500 that will receive a solution placebo. To date, AstraZeneca says, the vaccine has been administered to more than 320 healthy volunteers who show they are “safe and well tolerated“The results of this first phase are awaited.”for MayThen, starting in June, experimentation will be expanded to a larger sample of 5 thousand subjects.

Coronavirus, Italy and Britain work together on a vaccine: accelerated human trials in late April
Also read

Coronavirus, Italy and Britain work together on a vaccine: accelerated human trials in late April

“If the clinical trial will give positive results, as suggested by laboratory and animal tests, he saysAnsa Advent-Irbm president Pietro Di Lorenzo – by the end of the year we will have the availability of a first stock. It will be enough to start vaccination in more fragile bands of the population Obviously, to produce billions of doses for the general population. longer times, but the entry of the giant AstraZeneca will undoubtedly accelerate production capacity. “

Ilfattoquotidiano.it support: never like now
we need you.

In these weeks of pandemic, journalists, if we do our work with conscience,
We do a public service. That is why we are also proud every day here at ilfattoquotdiano.it
offer hundreds of new content for free to all citizens: news, exclusive ideas,
expert interviews, surveys, videos and much more. All this work, however, has a great economic cost.
Advertising, at a time when the economy is stagnant, offers limited income.
It is not in line with the access boom. So I ask those who read these lines to support us.
To give us a minimum contribution, equal to the price of a cappuccino per week,
fundamental to our work.
Become a support user by clicking here.

Thank you
Peter Gomez

But now we are the ones who need you.
Because our work has a cost.
We are proud to be able to offer hundreds of new content every day for free to all citizens.
But advertising, at a time when the economy is stagnant, offers limited income.
It is not in line with the boom in access to ilfattoquotidiano.it.
For this reason, I ask you to support us, with a minimum contribution equal to the price of one cappuccino per week.
A small but fundamental sum for our work. Help us
Become a support user!

With gratitude
Peter Gomez

ilFattoquotidiano.it

Support now

Payments available

Previous article

Coronavirus, US investigation USA: “Remdesivir antiviral reduces patient recovery time.” WHO: “For now it is experimental”

following

[ad_2]